Armed with CRISPR and a $38M round, eGenesis tackles the Holy Grail of xenotransplantation
The first crude research involving xenotransplantation goes back to the 1960s, when investigators first actively considered the possibilities of harvesting organs from primates for use in humans. That failed, and subsequent attempts running through the mid-90s also flopped, with incompatibility proving impossible to overcome, while also raising some big fears about transferring pig viruses to humans with potentially catastrophic results.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.